Related Experiment Video
Updated: Mar 22, 2026

13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
21.8K
Nanomaterial coatings applied on stent surfaces
Mahsa Bagheri1,2, Marzieh Mohammadi2, Terry Wj Steele3
1Shariati Hospital, Mashhad University of Medical Sciences, Mashhad, PO Box 935189-9983, Iran.
Nanomedicine (London, England)
|April 26, 2016
Summary
New stent designs using nanotechnology improve hemocompatibility, addressing restenosis and thrombosis. This review explores advanced polymers and biomaterials for next-generation cardiovascular stents.
Area of Science:
- Interventional Cardiology
- Biomaterials Science
- Nanotechnology
Background:
- Percutaneous coronary intervention and intravascular stents have transformed cardiology.
- In-stent restenosis, inflammation, and late-stent thrombosis remain significant challenges with current stents.
- Nanotechnology offers novel approaches to enhance stent hemocompatibility.
Purpose of the Study:
- To review promising polymers for next-generation stent fabrication.
- To discuss the impact of nanotechnology on stent development.
- To explore advancements in stent biomaterials in the context of atherosclerosis.
Main Methods:
- Literature review focusing on nanotechnology, biomaterials, and polymer science in cardiovascular stents.
- Synopsis of atherosclerosis and current commercialized stent technologies.
- Analysis of recent advancements in stent design and material science.
Main Results:
- Nanotechnology enables novel designs for localized drug/gene delivery and improved stent scaffolds.
- Advanced polymers and biomaterials are crucial for developing next-generation stents.
- Enhanced hemocompatibility is a key goal in overcoming current stent limitations.
Conclusions:
- Future stent generations will likely incorporate nanotechnology and advanced biomaterials.
- Addressing in-stent restenosis, inflammation, and thrombosis is critical for improving patient outcomes.
- Continued research into novel polymers and stent designs is essential for cardiovascular medicine.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Microbial Corrosion
16
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
16

